Sarcoma GOG 277

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase III Randomized Trial of Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for UterusLimited, High-Grade Uterine Leiomyosarcoma.